In alignment with our data, inhibition of NLRP3 inflammasome has shown to play a crucial part in ameliorating the cognitive deficits induced in diabetic rats following ischemia70, encephalomyelitis71, AD models68, and TBI models72. This evidence concerns the gene NLRP3 and Alzheimer disease.